EMD Ann: Emyria expands clinical sites for EMD-RX5 Phase 3 trial - 26th Sep 2022, 8:18am

annb0t

annb0t

Top 20
EMD Ann: Emyria expands clinical sites for EMD-RX5 Phase 3 trial
Price Sensitive: Y
Date: 26th Sep 2022, 8:18am

>>> Read announcement: Google: EMD Market Announcements
 
You must log in or register to reply here.

Similar threads

annb0t
EMD Ann: Emyria Secures Ethics Endorsement for MDMA AP Application - 30th Oct 2023, 9:23am
Replies
0
Views
67
annb0t
annb0t
annb0t
EMD Ann: Emyria's Clinic Achieves Key MDMA-AT Dosing Milestone - 9th Oct 2023, 9:15am
Replies
0
Views
60
annb0t
annb0t
annb0t
EMD Ann: Emyria Secures Local MDMA to Start PTSD Trial Dosing - 21st Sep 2023, 8:37am
Replies
0
Views
98
annb0t
annb0t
annb0t
EMD Ann: Emyria Completes Acquisition of the Pax Centre - 13th Sep 2023, 9:45am
Replies
0
Views
88
annb0t
annb0t
annb0t
EMD Ann: Emyria Gets $2M Bids, Sets $3.1M Entitlement Offer - 4th Sep 2023, 9:46am
Replies
0
Views
95
annb0t
annb0t
Top Bottom